Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System.
Pateras IS, Igea A, Nikas IP, Leventakou D, Koufopoulos NI, Ieronimaki AI, Bergonzini A, Ryu HS, Chatzigeorgiou A, Frisan T, Kittas C, Panayiotides IG. Pateras IS, et al. Int J Mol Sci. 2024 Jan 19;25(2):1251. doi: 10.3390/ijms25021251. Int J Mol Sci. 2024. PMID: 38279253 Free PMC article. Review.
Editorial: Infectious disease agents and cancer.
Igea A, Martin OCB, Cooks T, Pateras IS. Igea A, et al. Among authors: pateras is. Front Cell Dev Biol. 2024 Mar 12;12:1388423. doi: 10.3389/fcell.2024.1388423. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38533087 Free PMC article. No abstract available.
Rare cancer with primary pleural epithelioid hemangioendothelioma diagnosed by thoracoscopic biopsy achieving disease control after 16 months: case report and literature review.
Pateras IS, Kostopanagiotou K, Samaras MG, Koumarianou A, Koutrouli M, Korodimos N, Kampoli K, Apollonatou V, Manali E, Loukides S, Tomos P, Tsiodras S, Panayiotides IG. Pateras IS, et al. Front Pharmacol. 2024 Nov 22;15:1482154. doi: 10.3389/fphar.2024.1482154. eCollection 2024. Front Pharmacol. 2024. PMID: 39650162 Free PMC article.
Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes.
Ntostoglou K, Theodorou SDP, Proctor T, Nikas IP, Awounvo S, Sepsa A, Georgoulias V, Ryu HS, Pateras IS, Kittas C. Ntostoglou K, et al. Among authors: pateras is. Cancer Immunol Immunother. 2024 Feb 13;73(3):46. doi: 10.1007/s00262-024-03630-8. Cancer Immunol Immunother. 2024. PMID: 38349444 Free PMC article.
Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients.
Xagara A, Goulielmaki M, Fortis SP, Kokkalis A, Chantzara E, Christodoulopoulos G, Samaras I, Saloustros E, Tsapakidis K, Papadopoulos V, Pateras IS, Georgoulias V, Baxevanis CN, Kotsakis A. Xagara A, et al. Among authors: pateras is. Cancers (Basel). 2024 Jun 28;16(13):2393. doi: 10.3390/cancers16132393. Cancers (Basel). 2024. PMID: 39001455 Free PMC article.
79 results